United States · FDA National Drug Code directory
clenziderm m.d. system acne therapeutic system
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62032-613_bab0a250-f922-44f7-bd9e-517ebeb25fa7
- Product NDC
- 62032-613
- Form
- KIT
- Composition / generic term
- SALICYLIC ACID AND BENZOYL PEROXIDE
- Labeler
- Obagi Cosmeceuticals LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20120101
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (62032-613-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11) · 62032-613-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →